Prolonged Coagulopathy Related to Superwarfarin Overdose
- Sanjay Sarin, MD;
- Hamid Mukhtar, MD; and
- Mohd A. Mirza, MD
- From Geisinger Medical Center, Danville, PA 17822.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
Background: Superwarfarin poisoning is a growing public health problem in the United States and affects people of all ages, primarily children (1). Physicians must have a high index of suspicion for superwarfarin exposure when patients have unexplained coagulopathy resistant to vitamin K replacement and fresh frozen plasma.
Case Report: A 50-year-old man with a history of depression presented with hematuria, epistaxis, widespread ecchymosis of the skin, …
RSS Feeds









